<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>Heart Health on Guia GLP-1 — Ozempic, Wegovy, Mounjaro</title><link>https://glp1decode.com/pt/tags/heart-health/</link><description>Recent content in Heart Health on Guia GLP-1 — Ozempic, Wegovy, Mounjaro</description><image><title>Guia GLP-1 — Ozempic, Wegovy, Mounjaro</title><url>https://glp1decode.com/images/default-og.png</url><link>https://glp1decode.com/images/default-og.png</link></image><generator>Hugo</generator><language>pt</language><lastBuildDate>Tue, 16 Jun 2026 00:00:00 +0000</lastBuildDate><atom:link href="https://glp1decode.com/pt/tags/heart-health/index.xml" rel="self" type="application/rss+xml"/><item><title>Medicamentos GLP-1 e Saúde do Coração: O Que o SELECT e Outros Ensaios Revelam (2026)</title><link>https://glp1decode.com/pt/posts/glp1-heart-health-cardiovascular-benefits-2026/</link><pubDate>Tue, 16 Jun 2026 00:00:00 +0000</pubDate><guid>https://glp1decode.com/pt/posts/glp1-heart-health-cardiovascular-benefits-2026/</guid><description>Os medicamentos GLP-1 protegem o coração? Um mergulho profundo no ensaio SELECT e outras pesquisas de desfechos cardiovasculares — o que a semaglutida faz pelo risco de ataque cardíaco, AVC e morte cardiovascular em 2026.</description></item></channel></rss>